Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness
PRACTICE
Enhancing HIV-assisted Contact Tracing in Malawi Through Blended Learning: an Implementation Science Study
2 other identifiers
interventional
841
1 country
33
Brief Summary
Having health workers assist HIV-infected persons with the recruitment and testing of their sexual contacts and biological children is an effective and efficient way of identifying additional HIV-infected persons in need of HIV treatment and HIV-uninfected persons in need of HIV prevention. However, in Malawi, a country with a generalized HIV epidemic, health workers lack the counseling and coordination skills to routinely assist their HIV-infected clients with these services. This study will determine how to help health workers to effectively and efficiently provide these services to their patients through a set of digital capacity-building tools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
Typical duration for not_applicable
33 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
April 8, 2022
CompletedFirst Posted
Study publicly available on registry
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedResults Posted
Study results publicly available
February 6, 2025
CompletedFebruary 6, 2025
April 1, 2024
2.1 years
April 8, 2022
October 18, 2024
January 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Index Client Fidelity Assessment
Health care workers will be observed counseling actual index clients. The scores on the 15-item index client fidelity assessment will be compared between arms (range 0-100% with higher scores being better)
1 year after training
Contact Client Fidelity Assessment
Health care workers will be observed counseling actual contact clients. The scores on the 15-item contact client fidelity assessment will be compared between arms (range 0-100% with higher scores being better)
1 year after training
Index Clients Who Participate in Assisted Contact Tracing
The total number of index clients who participate in assisted contact tracing relative to the number of total potential index clients measured per facility per calendar quarter (3-month period). Each cluster contributes 4 quarters of data.
1 year after training
Contact Clients Elicited
The number of contact clients listed by participating index clients relative to the number of total potential index clients measured per facility per calendar quarter (3-month period). Each cluster contributes 4 quarters of data.
1 year after training
HIV Self-test Kits Distributed
The number of HIV self-test kits distributed relative to the number of total potential index clients measured per facility per calendar quarter (3-month period). Each cluster contributes 4 quarters of data.
1 year after training
Contact Clients Tested
The number of contact clients tested relative to the number of total potential index clients measured per facility per calendar quarter (3-month period). Each cluster contributes 4 quarters of data.
1 year after training
Contact Clients Living With HIV Identified
The number of contact clients living with HIV identified relative to the number of total potential index clients measured per facility per calendar quarter (3-month period). Each cluster contributes 4 quarters of data.
1 year after training
Incremental Cost Per Contact Tested
Incremental cost per contact tested for HIV = Total additional cost in enhanced arm ($127,319) / total number of additional individual tested for HIV in the enhanced arm (1119). The outcome is an incremental cost effectiveness ratio. Because no additional cost was incurred in the Standard arm, the value was reported as 0.
1 year after training
Incremental Cost Per Person Living With HIV Diagnosed
Incremental cost per contact tested for HIV = Total additional cost in enhanced arm ($127,319) / total number of additional individual diagnosed with HIV in the enhanced arm (64). The outcome is an incremental cost effectiveness ratio. Because no additional cost was incurred in the Standard arm, the value is reported as 0.
1 year after training
Study Arms (2)
Enhanced implementation strategy
EXPERIMENTALdigitally guided training and continuous quality improvement
Standard implementation strategy
ACTIVE COMPARATORstandard training and clinical support
Interventions
Individual training with teaching and modeling (tablet-guided, \~8 hours) Small group training with practice and feedback (tablet-guided, \~16 hours) Ongoing continuous quality improvement sessions (tablet-guided, \~2 hours/month)
Individual training with teaching (facilitator-guided, \~2 hours) Small group practice (facilitator-guided, \~1 hour) Ongoing clinic support (facilitator-guided, \~30 minutes/month)
Eligibility Criteria
You may qualify if:
- years of age or older
- working full-time at one of the health facilities included in the study
- staff in Malawi's Assisted Contact Tracing program.
You may not qualify if:
- conditions that would compromise ability of participant to provide informed consent, undergo study procedures safely, or prevent proper conduct of study
- \>=15 years
- potential index, contact, or parent or guardian of a potential index or contact
- conditions that would compromise ability of individual to provide informed consent, undergo study procedures safely, or prevent proper conduct of study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (33)
Balaka District Hospital
Balaka, Malawi
Balaka OPD Health Centre
Balaka, Malawi
Chiendausiku Health Centre
Balaka, Malawi
Kalembo Health Centre
Balaka, Malawi
Kankao Health Centre
Balaka, Malawi
Kwitanda Health Centre
Balaka, Malawi
Mbera Health Centre
Balaka, Malawi
Namanolo Health Centre
Balaka, Malawi
Namdumbo Health Centre
Balaka, Malawi
Phalula Health Centre
Balaka, Malawi
Phimbi Health Centre
Balaka, Malawi
Ulongwe Health Centre
Balaka, Malawi
Utale Health Centres
Balaka, Malawi
Chamba Dispensary
Machinga, Malawi
Chikweo Health Centre
Machinga, Malawi
Gawanani Health Centre
Machinga, Malawi
Kawinga Dispensary
Machinga, Malawi
Machinga District Hospital
Machinga, Malawi
Mahinga Health Centre
Machinga, Malawi
Mangamba Health Centre
Machinga, Malawi
Mbonechela Dispensary
Machinga, Malawi
Mkwepere Health Centre
Machinga, Malawi
Mpiri Health Centre
Machinga, Malawi
Mposa Health Centre
Machinga, Malawi
Namandanje Health Centre
Machinga, Malawi
Namanja Health Centre
Machinga, Malawi
Nayinunje Health Centre
Machinga, Malawi
Nayuchi Health Centre
Machinga, Malawi
Ngokwe health Centre
Machinga, Malawi
Nsanama Health Centre
Machinga, Malawi
Ntaja Health Centre
Machinga, Malawi
Nthorowa Health Centre
Machinga, Malawi
Nyambi Health Centre
Machinga, Malawi
Related Publications (3)
Meek CJ, Munkhondya TEM, Mphande M, Tembo TA, Chitani M, Jean-Baptiste M, Vansia D, Kumbuyo C, Wang J, Simon KR, Rutstein SE, Barrington C, Kim MH, Go VF, Rosenberg NE. Examining the feasibility of assisted index case testing for HIV case-finding: a qualitative analysis of barriers and facilitators to implementation in Malawi. BMC Health Serv Res. 2024 May 9;24(1):606. doi: 10.1186/s12913-024-10988-z.
PMID: 38720312DERIVEDTembo TA, Mollan K, Simon K, Rutstein S, Chitani MJ, Saha PT, Mbeya-Munkhondya T, Jean-Baptiste M, Meek C, Mwapasa V, Go V, Bekker LG, Kim MH, Rosenberg NE. Does a blended learning implementation package enhance HIV index case testing in Malawi? A protocol for a cluster randomised controlled trial. BMJ Open. 2024 Jan 22;14(1):e077706. doi: 10.1136/bmjopen-2023-077706.
PMID: 38253452DERIVEDMeek CJ, Munkhondya TEM, Mphande M, Tembo TA, Chitani M, Jean-Baptiste M, Vansia D, Kumbuyo C, Simon KR, Rutstein SE, Barrington C, Kim MH, Go VF, Rosenberg NE. Examining the feasibility of assisted index case testing for HIV case-finding: a qualitative analysis of barriers and facilitators to implementation in Malawi. Res Sq [Preprint]. 2023 Sep 8:rs.3.rs-3314925. doi: 10.21203/rs.3.rs-3314925/v1.
PMID: 37720011DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nora E. Rosenberg, PhD
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Nora E Rosenberg, PhD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participants and investigators will not be masked. For fidelity assessments, those coding audio recordings will be masked with respect to study arm.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2022
First Posted
April 25, 2022
Study Start
November 1, 2021
Primary Completion
November 30, 2023
Study Completion
November 30, 2023
Last Updated
February 6, 2025
Results First Posted
February 6, 2025
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Beginning 9 months after publication and continuing through 36 months of publication
- Access Criteria
- A repository will be selected that has policies and procedures in place that will provide data access to qualified researchers, fully consistent with NIH data sharing policies and applicable laws and regulations. The researcher will need approval form an Institutional Review Board and an executed data use/sharing agreement with University of North Carolina at Chapel Hill investigators.
At the end of the study, all data will be de-identified and shared in compliance with all regulatory bodies and NIH data sharing procedures.